Sunshine Guojian Pharmaceutical (Shanghai) Co (SHSE:688336) FFO


SHSE:688336 Sunshine Guojian Pharmaceutical (Shanghai) Co Ltd SHSE:688336
86 GF Score
Price ¥58.50
GF Value ¥66.69
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Sunshine Guojian Pharmaceutical (Shanghai) Co FFO?

FFO (Funds from operations) only applies to REITs.

SHSE:688336
86GF Score
Sunshine Guojian Pharmaceutical (Shanghai) Co Ltd SHSE:688336
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Sunshine Guojian Pharmaceutical (Shanghai) Co (SHSE:688336) Overvalued in 2026?

Based on GuruFocus' analysis, Sunshine Guojian Pharmaceutical (Shanghai) Co stock appears to be undervalued. The current stock price of ¥58.50 is trading 12.3% below its estimated GF Value™ of ¥66.69. GuruFocus considers Sunshine Guojian Pharmaceutical (Shanghai) Co to be Modestly Undervalued.

Key valuation signals for SHSE:688336:

  • FFO:
  • GF Value™: ¥66.69 vs. price of ¥58.50 (12.3% below fair value)
  • GF Score™: 86/100 with 3 warning signs

No single metric tells the full story. See the SHSE:688336 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sunshine Guojian Pharmaceutical (Shanghai) Co Business Description

Address No.399 Libing Road, China (Shanghai) Pilot Free Trade Zone, Shanghai, CHN, 201203
Sunshine Guojian Pharmaceutical (Shanghai) Co Ltd is a biopharmaceutical company providing safe and effective clinical solutions for the treatment of major diseases such as autoimmune diseases and tumors. The company engages in in research and development, manufacturing and commercialization of therapeutic antibody drugs in China. Its products portfolio includes YISAIPU and Xenopax. Its products in pipeline include 302H, 304R, 602, 601A, 609A and 301S.
86GF Score

Get the complete analysis for SHSE:688336

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥58.50
Price
¥66.69
GF Value